Skip to main content
Log in

20-Year MRI and CT Scan Follow-up of Pituitary Adenomas: Tumor Regression and the Implications for Radiotherapy

  • Published:
Journal of Radiosurgery

Abstract

Purpose/Objective: Pituitary adenomas are benign endocrine tumors that represent 10% of all intracranial neoplasms. These tumors have a variable growth rate and a variable response to hormonal manipulation, radiotherapy, or surgery. Surprisingly, very little information is available documenting regression of pituitary adenomas after surgery with serial imaging studies. To clearly define the postoperative regression rate of pituitary adenomas, we analyzed a group of 35 patients who had undergone surgery and pre- and postoperative imaging over a 20-year period. Materials and Methods: Between 1977 and 1997, 125 patients with pituitary macroadenomas were managed at our institution. Fourteen patients were observed without surgery or radiation. Follow-up MR and CT data were available for 73 patients; 38 patients received postoperative radiation; 38 patients were without adequate follow-up. The remaining 35 patients who underwent trans-sphenoidal hypophysectomy (TSH) alone comprise the cohort for analysis. To follow the changes in tumor size with time, individual measurements were obtained on all patients from CT and MR using standard response criteria, namely, the product of the two maximal orthogonal dimensions. Results: The mean follow-up period for all patients was 24.4 months. The age at diagnosis for all patients ranged from 20 to 78 years (mean 46.4 years). The mean initial and postoperative tumor maximal cross-sectional areas were 5.4 cm2 and 3.6 cm2, respectively. The mean time period to achieve a mean maximal decrease in postoperative tumor size of 2.9 cm2 was 3 months. Subsequently, at 6, 12, and 24 months, there was a 4%, 17%, and 21% respective increase in tumor size. Conclusion: Serial MRIs and CTs document that a significant decrease in tumor size is possible after TSH for pituitary macroadenomas. There appears, however, to be no benefit in observing patients beyond 3 months postoperatively as this is the nadir of tumor regression. Furthermore, tumor size appears to increase on 2-year follow-up. Since maximal tumor shrinkage is desired prior to XRT to reduce the RT dose received by the optic apparatus and normal brain tissues, these data may aid in determining when to administer postoperative radiation. Additional follow-up data on the value of observation and/or postoperative radiation may add to the current knowledge that is available on the natural history of treated or untreated pituitary macroadenomas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. Burrow GN, Wortzman G, Rewcastle NB, et al.: Microadenomas of the pituitary and abnormal sellar tomograms in an unselected autopsy series. N Eng J Med 304:156–158, 1981

    Google Scholar 

  2. Leavens ME, McCutcheon IF, Samaan NA: Management of pituitary adenomas. Oncology 6:69–79, 1992

    Google Scholar 

  3. McCutcheon IE: Pituitary tumors. In Cancer in the Nervous System. pp. 219–239

  4. Kovacs K, Horvath E: Tumors of the Pituitary Gland. Washington, DC: Armed Forces Institute of Pathology, 1986

    Google Scholar 

  5. Ebersold MJ, Quast LM, Laws ER, Scheithauer B, Randall RV: Long-term results in transsphenoidal removal of nonfunctioning pituitary adenomas. J Neurosurg 64:713–719, 1986

    Google Scholar 

  6. Halberg FE, Sheline GE: Radiotherapy of pituitary tumors. Endocrinol Metab Clin 16:667–684, 1987

    Google Scholar 

  7. Ciric I, Mikhael M, Stafford T, Lawson L, Garces R: Transsphenoidal microsurgery of pituitary macroadenomas with long-term follow-up results. J Neurosurg 59:395–401, 1983

    Google Scholar 

  8. Chun M, Masko G, Hatelekidis S: Radiotherapy in the treatment of pituitary adenomas. Int J Radiat Oncol Biol Phys 1:895–902, 1976

    Google Scholar 

  9. Parsons JT, Fitzgerald CR, Hood CI, Ellingwood KE, Bova FJ, Million RR: The effects of irradiation on the eye and optic nerve. Int J Radiat Oncol Biol Phys 9:609–622, 1983

    Google Scholar 

  10. McCullough WM, Marcus RB, Rhoton AL, Ballinger WE, Million RR: Long-term follow-up of radiotherapy for pituitary adenoma: The absence of late recurrence after >4500 cGy

  11. Movsas B, Movsas TZ, Steinberg SM, Okunieff P: Long-term visual changes following pituitary irradiation. Int J Radiat Oncol Biol Phys 33:599–605, 1995

    Google Scholar 

  12. Grigsby PW, Stokes S, Marks JE, Simpson JR: Prognostic factors and results of radiotherapy alone in the management of pituitary adenomas. Int J Radiat Oncol Biol Phys 15:1103–1110, 1988

    Google Scholar 

  13. Grigsby PW, Simpson JR, Emami BB, Fibeberg BB, Schwartz HG: Prognostic factors and results of surgery and postoperative irradiation in the management of pituitary adenomas. Int J Radiat Oncol Biol Phys 16:1411–1417, 1989

    Google Scholar 

  14. Grigsby PW: Pituitary adenomas: Evolving diagnosis and management. Int J Radiat Oncol Biol Phys 27:1253–1254, 1993

    Google Scholar 

  15. Hughes MN, Llamas KJ, Yelland ME, Obst D, Tripcony LB: Pituitary adenomas: Long-term results for radiotherapy alone and post-operative radiotherapy. Int J Radiat Oncol Biol Phys 27:1035–1044, 1993

    Google Scholar 

  16. Laws ER, Fode NC, Redmond MJ: Transsphenoidal surgery following unsuccessful prior therapy: An assessment of benefits and risk in 158 patients. J Neurosurg 63:823–829, 1985

    Google Scholar 

  17. Dowsett RJ, Fowble B, Sergott RC, Savino PJ, Bosley TM, Snyder PJ, Gennarelli TA: Results of radiotherapy in the treatment of acromegaly: Lack of ophthalmologic complications. Int J Radiat Oncol Biol Phys 19:453–549, 1990

    Google Scholar 

  18. Koppelman MCS, Jaffe MJ, Rieth KG, Caruso RC, Loriaux DL: Hyperprolactinemia, amenorrhea and galactorrhea: A retrospective analysis of twenty-five cases. Ann Intern Med 100:115–121, 1984

    Google Scholar 

  19. Zierhut D, Flentje M, Adolph J, Erdmann J, Raue F, Wannenmacher M: External radiotherapy of pituitary adenomas. Int J Radiat Oncol Biol Phys 33:307–314, 1995

    Google Scholar 

  20. Gonzalez ER: To treat or not to treat: Hyperprolactinemia. JAMA 248:515–516, 1982

    Google Scholar 

  21. Schlechte J, Dolan K, Sherman B, Chapler F, Luciano A: The natural history of untreated hyperprolactinemia: A prospective analysis. J Clin Endocrinol Metab 68:412–418, 1989

    Google Scholar 

  22. Rush SC, Newall J: Pituitary adenoma: The efficacy of radiotherapy as the sole treatment. Int J Radiat Oncol Biol Phys 17:165–169, 1989

    Google Scholar 

  23. Weiss MH, Teal J, Gott P, Wycoff R, Yadley R, Apuzzo MLJ, Giannotta SL, Kletsky O, March C: Natural history of microprolactinomas: Six-year follow-up. Neurosurgery 12:180–183, 1983

    Google Scholar 

  24. Hemminghytt P, Kalkhoff D, Daniels D, Williams P, Haughton V: Computed tomographic study of hormone-secreting microadenomas. Neuroradiology 146:65–69, 1983

    Google Scholar 

  25. Dietmann JL, Portha C, Cattin F, Mollet E, Bonneville JF: CT follow-up of microprolactinomas during bromocriptine-induced pregnancy. Neuroradiology 25:133–138, 1983

    Google Scholar 

  26. Sisam DA, Sheehan JP, Sheeler LR: The natural history of untreated microprolactinomas. Fertility and Sterility 48:67–71, 1987

    Google Scholar 

  27. March CM, Kletzky OA, Dvajan V, Teal J, Weiss M, Apuzzo MLJ, Marrs RP, Mishell DR: Longitudinal evaluation of patients with untreated prolactin-secreting pituitary adenomas. Am J Obstet Gynecol 139:835–844, 1981

    Google Scholar 

  28. Estrada J, Boronat M, Mielgo M, Magallon R, Millan I, Diez S, Lucas T, Barcelo B: The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing's disease. N Engl J Med 336:172–177, 1997

    Google Scholar 

  29. Corn BW, Yousem DM, Scott CB, Rotman M, Asbell SO, Nelson D, Martin L, Curran WJ: White matter changes are correlated significantly with radiation dose. Cancer 74:2828–2835, 1994

    Google Scholar 

  30. Tsang RW, Laperriere NJ, Simpson WJ, Brierley J, Panzarella T, Smyth HS: Glioma arising after radiation therapy for pituitary adenoma. Cancer 72:2227–2233, 1993

    Google Scholar 

  31. Constine LS, Konski A, Ekholm S, McDonald S, Rubin P: Adverse effects of brain irradiation correlated with MR and CT imaging. Int J Radiat Oncol Biol Phys 15:319–330, 1988

    Google Scholar 

  32. Curran WJ, Hecht-Leavitt C, Schut L, Zimmerman RA, Nelson DF: Magnetic resonance imaging of cranial radiation lesions. Int J Radiat Oncol Biol Phys 13:1093–1098, 1987

    Google Scholar 

  33. Al-Mefty O, Kersh JE, Routh A, Smith RR: The long-term side effects of radiation therapy for benign brain tumors in adults. J Neurosurg 73:502–512, 1990

    Google Scholar 

  34. Brada M, Ford D, Ashley S, Bliss JM, Crowley S, Mason M, Rajan B, Traish D: Risk of second brain tumor after conservative surgery and radiotherapy for pituitary adenoma. BMJ 304: 1343–1345, 1992

    Google Scholar 

  35. Jones A: Radiation oncogenesis in relation to the treatment of pituitary tumours. Clin Endocrinol 35:379–397, 1991

    Google Scholar 

  36. Gill SS, Thomas DG, et al.: Relocatable frame for stereotactic external beam radiotherapy. Int J Radiat Oncol Biol Phys 29:599–603, 1991

    Google Scholar 

  37. Tran LM, Blount L, Horton D, Sedeghi A, Parker RG: Radiation therapy of pituitary tumors: Results in 95 cases. Am J Clin Oncol 14:25–29, 1991

    Google Scholar 

  38. Ron E, Modan B, Boice JD, et al.: Tumors of the brain and the central nervous system after radiotherapy in childhood. N Engl J Med 319:1033–1039, 1988

    Google Scholar 

  39. Waltz TA, Brownell B: Sarcoma: A possible late result of effective radiation therapy for pituitary adenoma. Report of two cases. J Neurosurg 24:901–907, 1966

    Google Scholar 

  40. Shi T, Farrell MA, Kaufmann JCE: Fibresarcoma complicating irradiated pituitary adenoma. No Shinkei Geka 8:605–614, 1980

    Google Scholar 

  41. Souhami et al.: Fractionated stereotactic radiation therapy for intracranial tumors. Cancer 68:2102–2108, 1991

    Google Scholar 

  42. Dunbar et al.: Stereotactic radiotherapy for pediatric and adult brain tumors: Preliminary report. Int J Radiat Oncol Biol Phys 30:531–539, 1994

    Google Scholar 

  43. Harris JR, Levine MB: Visual complications following irradiation for pituitary adenomas and craniopharyngiomas. Radiology 120:167–171, 1976

    Google Scholar 

  44. Cohen MS, Kushner MJ, Dell S: Frontal lobe astrocytoma following radiotherapy for medulloblastoma. Neurology 31:616–619, 1981

    Google Scholar 

  45. Marus G, Levin CV, Rutherford GS: Malignant glioma following radiotherapy for unrelated primary tumors. Cancer 58:886–894, 1986

    Google Scholar 

  46. Rubenstein AB, Shalit MN, Cohen ML, et al.: Radiation-induced cerebral meningioma: A recognizable entity. J Neurosurg 61:966–971, 1984

    Google Scholar 

  47. Soffer D, Pittaluga S, Feiner M, et al.: Intracranial meningiomas following low-dose irradiation to the head. J Neurosurg 48:622–627, 1978

    Google Scholar 

  48. Devita VT, Hellman S, Rosenberg SA. (eds): Cancer, Principles and Practices of Oncology. J.B. Lippincott Co., 1993

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Coke, C., Fitzpatrick, M., Corn, B. et al. 20-Year MRI and CT Scan Follow-up of Pituitary Adenomas: Tumor Regression and the Implications for Radiotherapy. Journal of Radiosurgery 2, 199–203 (1999). https://doi.org/10.1023/A:1022935117171

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1022935117171

Navigation